For R&D use only.

Geldanamycin

  • Catalog NO.:A820435
  • CAS No. : 30562-34-6
  • Molecular Formula:C29H40N2O9
  • Molecular Weight: 560.64
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
SDS COA

Product Details

CAS Number 30562-34-6 Appearance Yellow crystalline powder
Catalog Number A820435 MDL Number MFCD00274570
Molecular Formula C29H40N2O9 Molecular Weight 560.64
Boiling Point Melting Point 270-274°C
Flash Point Density
Synonyms NSC122750; U 29135;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H315; H319; H335 Class
Precautionary Statements P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501 Packing Group

Description

Geldanamycin is a benzoquinone ansamycin antibiotic that binds to Hsp90 (Heat Shock Protein 90) and inhibits its function. HSP90 client proteins play important roles in the regulation of the cell cycle, cell growth, cell survival, apoptosis, angiogenesis and oncogenesis. Hsp90-geldanamycin complex. PDB 1yet Geldanamycin induces the degradation of proteins that are mutated in tumor cells such as v-Src, Bcr-Abl and p53 preferentially over their normal cellular counterparts. This effect is mediated via HSP90. Despite its potent antitumor potential, geldanamycin presents several major drawbacks as a drug candidate (namely, hepatotoxicity) that have led to the development of geldanamycin analogues.

Related Products

My Tracks: Geldanamycin
Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Geldanamycin
NSC122750; U 29135;(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate